Scientific Sessions 2012 travels to Los Angeles

April 05, 2012 Categories: Heart News, Scientific Conferences & Meetings
DALLAS, April 5, 2012 ― For the first time in more than a decade, the American Heart Association’s Scientific Sessions meeting returns to the west coast at the Los Angeles Convention Center, Nov. 3-7.
The association expects more than 20,000 scientists and healthcare professionals from 110 countries to attend Scientific Sessions, the largest gathering devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases.
The theme of Scientific Sessions 2012 – “Leading Discovery. Global Impact.” – highlights the comprehensive nature of scientific presentations and the importance of the international collaboration taking place among thousands of cardiovascular disease experts.
At Sessions, the world’s top leaders in cardiovascular disease will give more than 4,000 scientific presentations and 300 exhibitors are expected to showcase the latest cardiovascular technology and resources.
Late Breaking Clinical Trial sessions allow researchers to present new, potentially practice-changing research advances to attendees. Approximately 16-20 late breaking clinical trials are expected to be presented at Sessions 2012.
Science programming at Sessions is divided into seven, color-coded cardiovascular cores, which help integrate the concepts of basic, clinical, population and translational science. The cores are designed to help attendees to interact with colleagues across disciplines. Within these cores are 15 programming tracks, designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives.
“Despite being one of the largest meetings of its kind, Scientific Sessions offers unique opportunities for interaction and instruction among various specialties,” said Elliott Antman, M.D., chair, Committee on Scientific Sessions Program. “The scope and quality of scientific exchange at Scientific Sessions makes it the premier cardiovascular research and instructional meeting in the world.”
A new feature at this year’s Scientific Sessions will be taped case sessions.  During each case session, attendees will watch recorded procedures and may ask questions of the moderator. The cases will target interventional cardiologists, surgeons, and electrophysiologists.
Each year, Sessions holds an international congress to address specific topics of global interest. This year, The International Congress on Valvular Heart Disease: New Treatments for a Global Cardiovascular Problem will offer a global perspective on the epidemiology, pathophysiology, diagnosis and treatment options for valvular heart disease.
The American Heart Association operates a news media center at Sessions, which offers media briefings, news conferences, interview opportunities and a working news room to help the media get important science news to the public. In 2011, nearly 300 media attended, who generated more than 5,000 articles and news stories. 
For general information, visit Scientific Sessions 2012. Media and member registration starts June 6, 2012; visit Sessions 2012 registration for more information.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events.  The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at
CORP12 – 1000
For Media Inquiries: (214) 706-1173
Tagni McRae: (214) 706-1382;
Bridgette McNeill: (214) 706-1135;
Julie Del Barto (broadcast): (214) 706-1330;
For Public Inquiries: (800) AHA-USA1 (242-8721)